These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19949668)

  • 1. Surfactant therapy for neonatal respiratory distress syndrome: a review of Korean experiences over 17 years.
    Bae CW; Hahn WH
    J Korean Med Sci; 2009 Dec; 24(6):1110-8. PubMed ID: 19949668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary Surfactant Replacement Therapy for Respiratory Distress Syndrome in Neonates: a Nationwide Epidemiological Study in Korea.
    Shin JE; Yoon SJ; Lim J; Han J; Eun HS; Park MS; Park KI; Lee SM
    J Korean Med Sci; 2020 Aug; 35(32):e253. PubMed ID: 32808509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of natural surfactant on mortality and morbidity in neonates with a birth weight below 1500 grams].
    Stranák Z; Janota J; Miletín J; Simák J
    Ceska Gynekol; 2000 Dec; 65 Suppl 1():38-42. PubMed ID: 11394231
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epidemiological survey of neonatal respiratory distress syndrome in part of northwest regions in China].
    Network of Northwest Neonatal Professional Collaboration Group
    Zhonghua Er Ke Za Zhi; 2015 May; 53(5):341-7. PubMed ID: 26080663
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Efficacy analysis of different pulmonary surfactants in premature infants with respiratory distress syndrome].
    Xu H; Xu P
    Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2021 Feb; 33(2):174-179. PubMed ID: 33729136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter, randomized, masked, comparison trial of lucinactant, colfosceril palmitate, and beractant for the prevention of respiratory distress syndrome among very preterm infants.
    Moya FR; Gadzinowski J; Bancalari E; Salinas V; Kopelman B; Bancalari A; Kornacka MK; Merritt TA; Segal R; Schaber CJ; Tsai H; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1018-29. PubMed ID: 15805380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Clinical characteristics and outcomes of respiratory distress syndrome in term and late-preterm neonates].
    Chen A; Shi LP; Zheng JY; Du LZ
    Zhonghua Er Ke Za Zhi; 2008 Sep; 46(9):654-7. PubMed ID: 19099850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the effects of surfactant replacement therapy in neonatal respiratory distress syndrome.
    Ghaemi S; Mohamadymasodi M; Kelishadi R
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 Mar; 11(3):188-90. PubMed ID: 19292953
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patent ductus arteriosus hemodynamics in very premature infants treated with poractant alfa or beractant for respiratory distress syndrome.
    Fujii A; Allen R; Doros G; O'Brien S
    J Perinatol; 2010 Oct; 30(10):671-6. PubMed ID: 20336077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multicenter randomized masked comparison trial of synthetic surfactant versus calf lung surfactant extract in the prevention of neonatal respiratory distress syndrome.
    Hudak ML; Martin DJ; Egan EA; Matteson EJ; Cummings NJ; Jung AL; Kimberlin LV; Auten RL; Rosenberg AA; Asselin JM; Belcastro MR; Donohue PK; Hamm CR; Jansen RD; Brody AS; Riddlesberger MM; Montgomery P
    Pediatrics; 1997 Jul; 100(1):39-50. PubMed ID: 9200358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of two different early rescue surfactant treatments on mortality in preterm infants with respiratory distress syndrome.
    Kadıoğlu Şimşek G; Kanmaz Kutman HG; Canpolat FE; Oğuz ŞS
    Clin Respir J; 2020 Mar; 14(3):285-290. PubMed ID: 31814293
    [TBL] [Abstract][Full Text] [Related]  

  • 12. History of Pulmonary Surfactant Replacement Therapy for Neonatal Respiratory Distress Syndrome in Korea.
    Bae CW; Kim CY; Chung SH; Choi YS
    J Korean Med Sci; 2019 Jul; 34(25):e175. PubMed ID: 31243934
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multicenter, randomized, controlled trial of lucinactant versus poractant alfa among very premature infants at high risk for respiratory distress syndrome.
    Sinha SK; Lacaze-Masmonteil T; Valls i Soler A; Wiswell TE; Gadzinowski J; Hajdu J; Bernstein G; Sanchez-Luna M; Segal R; Schaber CJ; Massaro J; d'Agostino R;
    Pediatrics; 2005 Apr; 115(4):1030-8. PubMed ID: 15805381
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Repeat surfactant therapy for postsurfactant slump.
    Katz LA; Klein JM
    J Perinatol; 2006 Jul; 26(7):414-22. PubMed ID: 16724122
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Compare severity of bronchopulmonary dysplasia in neonates with respiratory distress syndrome treated with surfactant to without surfactant.
    Chotigeat U; Ratchatanorravut S; Kanjanapattanakul W
    J Med Assoc Thai; 2011 Aug; 94 Suppl 3():S35-40. PubMed ID: 22043752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surfactant replacement therapy with a single postventilatory dose of a reconstituted bovine surfactant in preterm neonates with respiratory distress syndrome: final analysis of a multicenter, double-blind, randomized trial and comparison with similar trials. The Surfactant-TA Study Group.
    Fujiwara T; Konishi M; Chida S; Okuyama K; Ogawa Y; Takeuchi Y; Nishida H; Kito H; Fujimura M; Nakamura H
    Pediatrics; 1990 Nov; 86(5):753-64. PubMed ID: 2235230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mortality risk factors in premature infants with respiratory distress syndrome treated by mechanical ventilation].
    Fidanovski D; Milev V; Sajkovski A; Hristovski A; Sofijanova A; Kojić L; Kimovska M
    Srp Arh Celok Lek; 2005; 133(1-2):29-35. PubMed ID: 16053172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined effects of antenatal corticosteroids and surfactant supplementation on the outcome of very low birth weight infants.
    Modanlou HD; Beharry K; Padilla G; Iriye B
    J Perinatol; 1996; 16(6):422-8; quiz 429-30. PubMed ID: 8979178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndrome.
    Pfister RH; Soll R; Wiswell TE
    Cochrane Database Syst Rev; 2009 Oct; (4):CD006180. PubMed ID: 19821357
    [TBL] [Abstract][Full Text] [Related]  

  • 20. INSURE method (INtubation-SURfactant-Extubation) in early and late premature neonates with respiratory distress: factors affecting the outcome and survival rate.
    Naseh A; Yekta BG
    Turk J Pediatr; 2014; 56(3):232-7. PubMed ID: 25341593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.